Stocks To Watch on July 15
Stocks to watch: Shares of firms like HCL Tech, IREDA, DMart, Marico, RVNL, Zomato, Central Bank, and others will be in focus on Monday’s trade.
Stocks To Watch On July 15: Domestic markets experienced one of the best weeks in 2024 with Nifty and Sensex extending closing at record highs last week. In today’s trade, shares of HCL Tech, DMart, Jio Financial, HDFC Life, Kotak Bank among others will be in focus due to news developments and first quarter results.
HDFC Life, Jio Financial, HDFC AMC, Angel One, SpiceJet
Shares of HDFC Life, Jio Financial, HDFC AMC, Angel One and SpiceJet will be in focus as the companies will announce their first quarter results today.
HCL Technologies: HCL Technologies reported a 6.8 per cent increase in net profit to Rs 4,257 crore for Q1, despite a 1.6 per cent drop in revenue to Rs 28,057 crore and a 4.4 per cent decline in Ebit to Rs 4,795 crore. The Ebit margin slipped from 17.6 per cent to 17.1 per cent. Dollar revenue fell 1.9 per cent, and constant currency revenue decreased 1.6 per cent.
The company forecasts a 3-5 per cent year-on-year revenue growth in constant currency for FY25 and expects an Ebit margin of 18-19 per cent. An interim dividend of Rs 12 per share was declared.
5paisa Capital: 5paisa Capital achieved a 39 per cent jump in net profit to Rs 20.1 crore, with revenue growing by 21 per cent to Rs 102.3 crore in Q1 on a consolidated basis.
IREDA: Indian Renewable Energy Development Agency (IREDA) reported a 30.2 per cent spike in net profit to Rs 383.7 crore for Q1, alongside a 37.6 per cent increase in net interest income to Rs 507.8 crore year-on-year.
Avenue Supermarts: Avenue Supermarts (DMart) saw a 17.5 per cent increase in net profit to Rs 774 crore, with revenue rising by 18.6 per cent to Rs 14,069 crore in Q1. Ebitda surged 18 per cent to Rs 1,221 crore, maintaining a flat margin at 8.7 per cent on a consolidated basis.
Marico: Marico aims for double-digit revenue growth in the medium term, with domestic revenue expected to outpace volume growth from Q1FY25.
RVNL: Rail Vikas Nigam secured a Letter of Acceptance (LoA) for a project worth Rs 132.6 crore from Central Railway for OHE modification work in Nagpur division.
Alembic Pharmaceuticals: Alembic Pharmaceuticals received tentative US FDA approval for Selexipag for injection, indicated for pulmonary arterial hypertension treatment.
Geojit Financial Services: Geojit Financial Services witnessed a 107.5 per cent increase in net profit to Rs 45.81 crore, as revenue jumped 56.2 per cent to Rs 181.2 crore in Q1 on a consolidated basis.
Lupin: Lupin received an Establishment Inspection Report (EIR) from the US FDA for its Gujarat facility with no observations noted during the inspection period.
Piramal Pharma: Piramal Pharma completed a Pre-Approval Inspection (PAI) at its PPDS Ahmedabad facility by the US FDA with no Form 483 observations.
Apollo Micro Systems: Apollo Micro Systems won a Make II project from the Indian Army for a Vehicle Mounted Counter Swarm Drone System (VMCSDS) (Version I).
Suven Pharma: Suven Pharmaceuticals received a Form 483 with two procedural observations following a US FDA inspection of Casper Pharma in Hyderabad and acquired a 51 per cent stake in Sapala Organics.
Zomato: Zomato dissolved its step-down subsidiary, Zomato Slovakia, effective July 12.
Central Bank of India: Central Bank of India entered a strategic co-lending partnership with Arka Fincap to offer MSME loans.
Jupiter Wagons: Jupiter Wagons raised Rs 800 crore through a qualified institutional placement (QIP), which received 3.5 times oversubscription.
PTC India Financial Services: PTC India Financial Services appointed R Balaji as MD & CEO, effective July 12.
Bank of Maharashtra: Bank of Maharashtra will consider raising long-term bonds through a public issue or private placement during FY25 in its upcoming board meeting on July 18.
Disclaimer:Disclaimer: The views and investment tips by experts in this News18.com report are their own and not those of the website or its management. Users are advised to check with certified experts before taking any investment decisions.
